The Australian medical landscape is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing remarkable results in clinical trials for managing obesity. This medication https://bookmarkoffire.com/story21673627/the-new-retatrutide-australia-a-potential-prospect-for-weight-management